(Q37945579)

English

High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.

scientific article published on October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jennifer Kieran

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

A Dillon

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

G Farrell

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

A Jackson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

S Norris

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

F Mulcahy

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C Bergin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

International Journal of STD & AIDS

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

571-576

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 years.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Limited uptake of hepatitis C treatment among injection drug users

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Effect of race and HIV co-infection upon treatment prescription for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Role of rapid virological response in prediction of sustained virological response to Peg-IFN plus ribavirin in HCV / HIV co-infected individuals

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Haematological support during peg-interferon therapy for HCV-infected haemophiliacs improves virological outcomes

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

A review of barriers and facilitators of HIV treatment among injection drug users.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Telaprevir for chronic HCV infection

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

A systematic approach to the treatment of HIV and hepatitis C virus infection in the inner city: a Canadian perspective

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Antiretroviral medication use among injection drug users: two potential futures

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Predictors and Consequences of Negative Physician Attitudes Toward HIV-Infected Injection Drug Users

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010416

21 January 2018

Identifiers

10.1258/IJSA.2011.010416

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21998177%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37945579&oldid=2151521319"